Moreover, RAs and their receptors (RARs and RXRs) have an important role in eye development and physiology [104], and in a recent study, Prat et al. demonstrated that myocilin (a pathogenic genetic biomarker for glaucoma) expression is regulated by RA via the RARE-DR2 promotor [105]. This evidence concerns the gene MYOC and glaucoma.